{
  "openalex_id": "W2400113653",
  "doi": "https://doi.org/10.7326/acpjc-2005-142-2-051",
  "title": "Renal impairment increased mortality and cardiovascular complications after myocardial infarction",
  "abstract": "EtiologyMarch 1, 2005Renal impairment increased mortality and cardiovascular complications after myocardial infarctionAmit X. Garg, MD, MA, FRCPCAmit X. Garg, MD, MA, FRCPCLondon Health Sciences Centre, London, Ontario, Canada (A.X.G.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/ACPJC-2005-142-2-051 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack Citations ShareFacebookTwitterLinkedInRedditEmail Source CitationAnavekar NS, McMurray JJ, Velazquez EJ, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004;351:1285-95. https://pubmed.ncbi.nlm.nih.gov/15385655Clinical Impact RatingsGIM/FP/GP: Cardiology: Nephrology: References1 Tonelli M, Isles C, Curhan GC, et al. Effect of pravastatin on cardiovascular events in people with chronic kidney disease. Circulation. 2004;110:1557-63. [PMID: 15364796] Google Scholar2 Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med. 2001;134:629-36. [PMID: 11304102] Google Scholar3 Nissenson AR, Collins AJ, Hurley J, et al. Opportunities for improving the care of patients with chronic renal insufficiency: current practice patterns. J Am Soc Nephrol. 2001;12:1713-20. [PMID: 11461944] Google Scholar4 Wanner C, Krane V, Marz W, et al. Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study): demographic and baseline characteristics. Kidney Blood Press Res. 2004;27:259-66. Epub 2004 Aug 16. [PMID: 15316128] Google Scholar Author, Article, and Disclosure InformationAffiliations: London Health Sciences Centre, London, Ontario, Canada (A.X.G.) PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoReduced glomerular filtration rate was associated with increased death, cardiovascular events, and hospitalization Amit X. Garg March 1, 2005Volume 142, Issue 2Page: 51KeywordsCardiovascular disease riskClinical trialsCreatinineDeath ratesDietEnzyme inhibitorsForecastingGlomerular filtration rateHeartHeart failureHospitalizationsMedical risk factorsMorbidityMyocardial infarctionNephrologyPrevention, policy, and public healthRenal diseasesResuscitationStatinsStroke ePublished: 9 March 2020 Issue Published: March 1, 2005 Copyright & PermissionsCopyright Â© 2005 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...",
  "authors": [
    {
      "display_name": "Amit X. Garg",
      "id": "A5001731019",
      "orcid": "https://orcid.org/0000-0003-3398-3114",
      "institutions": [
        {
          "id": "I2800925808",
          "display_name": "London Health Sciences Centre",
          "country_code": "CA",
          "type": "healthcare"
        }
      ],
      "is_corresponding": true,
      "raw_author_name": "Amit X. Garg"
    }
  ],
  "publication_year": 2005,
  "publication_date": "2005-03-01",
  "type": "article",
  "cited_by_count": 1,
  "is_retracted": false,
  "is_paratext": false,
  "language": "en",
  "source": {
    "id": "S2754129969",
    "display_name": "ACP Journal Club",
    "issn_l": "1056-8751",
    "issn": [
      "1056-8751",
      "1083-1541",
      "1539-8560"
    ],
    "type": "journal",
    "host_organization": "https://openalex.org/P4310316812"
  },
  "volume": "142",
  "issue": "2",
  "first_page": "51",
  "last_page": "51",
  "open_access": {
    "is_oa": false,
    "oa_status": "closed",
    "oa_url": null,
    "any_repository_has_fulltext": false
  },
  "concepts": [
    {
      "id": "C71924100",
      "display_name": "Medicine",
      "level": 0,
      "score": 0.92636985
    },
    {
      "id": "C126322002",
      "display_name": "Internal medicine",
      "level": 1,
      "score": 0.65289956
    },
    {
      "id": "C500558357",
      "display_name": "Myocardial infarction",
      "level": 2,
      "score": 0.5780884
    },
    {
      "id": "C2778653478",
      "display_name": "Kidney disease",
      "level": 2,
      "score": 0.5691325
    },
    {
      "id": "C168563851",
      "display_name": "Randomized controlled trial",
      "level": 2,
      "score": 0.5422067
    },
    {
      "id": "C54847362",
      "display_name": "Nephrology",
      "level": 2,
      "score": 0.516162
    },
    {
      "id": "C2778063415",
      "display_name": "Hemodialysis",
      "level": 2,
      "score": 0.4942129
    },
    {
      "id": "C2777482532",
      "display_name": "Atorvastatin",
      "level": 2,
      "score": 0.45103204
    },
    {
      "id": "C2779519902",
      "display_name": "Pravastatin",
      "level": 3,
      "score": 0.4455797
    },
    {
      "id": "C164705383",
      "display_name": "Cardiology",
      "level": 1,
      "score": 0.44261792
    },
    {
      "id": "C2778163477",
      "display_name": "Cholesterol",
      "level": 2,
      "score": 0.15994412
    }
  ],
  "topics": [
    {
      "id": "T10144",
      "display_name": "Blood Pressure and Hypertension Studies",
      "score": 0.9901
    },
    {
      "id": "T10408",
      "display_name": "Chronic Kidney Disease and Diabetes",
      "score": 0.9887
    },
    {
      "id": "T10372",
      "display_name": "Cardiac Imaging and Diagnostics",
      "score": 0.9798
    }
  ],
  "created_date": null,
  "updated_date": null,
  "indexed_in": [],
  "landing_page_url": "https://doi.org/10.7326/acpjc-2005-142-2-051",
  "pdf_url": null,
  "retrieved_date": "2025-07-30T14:35:06.483564",
  "source_database": "OpenAlex"
}